Were you or a loved one diagnosed with cancer after taking Belviq?
On February 13, 2020, the FDA has requested that the manufacturer of Belviq, Belviq XR (lorcaserin) (a popular weight-loss drug) voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of cancer. If you or a loved one was prescribed Belviq and developed cancer, you should contact The Patrick Yancey Law Firm right away.
Cancers Belviq has been linked to:
- Pancreatic Cancer
- Colorectal Cancer
- Lung Cancer
- Other Cancers